Patient Demographics
Patient Age
Evaluation
Breast Evaluation Finding and Biopsy Result
Evaluation
Benign Finding — Observe or Excise
Evaluation
Suspicious Mass — Proceed to Biopsy
Evaluation
Cyst: Aspiration and Result
Evaluation
Simple Cyst — Discharge / Observe
Staging
Breast Cancer Staging
Genetic Risk Assessment
Genetic Risk Factors
Genetic Risk Assessment
Genetic Counselling Referral
Genetic Risk Assessment
Genetic Counselling — Age < 40
Surgery — Operable BC
Breast Conservation Surgery (BCS) Preference
Surgery — Operable BC
Surgery: Breast Conservation Surgery
Surgery — Operable BC
Surgery: Mastectomy
Surgery — Operable BC
Response to Neoadjuvant Chemotherapy (NACT)
Surgery — Operable BC
Post-NACT: BCS Now Feasible
Surgery — Operable BC
Post-NACT: Mastectomy Required
Axilla — Operable BC
Node-negative — Axilla Management
Axilla — Operable BC
Node-positive (N1) — Complete Axillary Dissection
Axilla — Operable BC
Advanced Node-positive: Axilla Management
Locally Advanced BC
MRM Feasibility
Locally Advanced BC
LABC: Upfront MRM
Locally Advanced BC
Response to NACT in LABC
Locally Advanced BC
LABC Post-NACT: Surgery
Locally Advanced BC
LABC No Response to NACT
Post-NACT Assessment
TNBC: Pathological Complete Response (pCR) After NACT?
Post-NACT Assessment
TNBC Post-NACT: pCR Achieved
Post-NACT Assessment
TNBC Post-NACT: No pCR — Maintenance Capecitabine
Post-NACT Assessment
HER2+: Pathological Complete Response (pCR) After NACT + Anti-HER2?
Post-NACT Assessment
HER2+ Post-NACT: pCR Achieved
Post-NACT Assessment
HER2+ Post-NACT: No pCR — Adjuvant TDM1
Post-NACT Assessment
LABC TNBC: pCR After NACT?
Post-NACT Assessment
LABC HER2+: pCR After NACT + Anti-HER2?
Systemic Therapy
Hormone Receptor & HER2 Status
Systemic Therapy
Hormone Receptor & HER2 Status (LABC)
Systemic Therapy
Tumour Grade
Systemic Therapy
Invasive Tumour Size (pT)
Systemic Therapy
Endocrine-Only Criteria: ER/PR Strength and Menopausal Status
Systemic Therapy
Luminal T1/T2 N0 Low-risk: Endocrine Therapy Only
Systemic Therapy
Luminal T1/T2 N0: Chemotherapy Regimens
Systemic Therapy
Luminal Advanced / Node-positive: Chemotherapy Regimens
Systemic Therapy
LABC Luminal: Chemotherapy Regimens
Systemic Therapy
TNBC T1/T2 N0: Chemotherapy Regimens
Systemic Therapy
TNBC Node-positive/Advanced: Chemotherapy Regimens
Systemic Therapy
TNBC Advanced / Node-positive: Chemotherapy Regimens (LABC)
Systemic Therapy
HER2+ T1/T2 N0: Chemotherapy + Trastuzumab
Systemic Therapy
HER2+ Node-positive/Advanced: Chemotherapy + Trastuzumab
Systemic Therapy
HER2+ Advanced / Node-positive: Chemotherapy + Trastuzumab (LABC)
Hormone Therapy
Hormone Therapy: Menopausal Status
Hormone Therapy
Premenopausal: Risk Stratification
Hormone Therapy
Premenopausal — Standard Risk: Hormone Therapy
Hormone Therapy
Premenopausal — High Risk: Hormone Therapy
Hormone Therapy
Postmenopausal: Hormone Therapy Options
Targeted Therapy
HER2+ Targeted Therapy: Trastuzumab
Radiation Therapy
Surgery Type for Radiation Planning (LABC)
Radiation Therapy
Stage for Post-Mastectomy Radiation (LABC)
Radiation Therapy
Post-Mastectomy RT: DCIS (LABC)
Radiation Therapy
Post-Mastectomy RT: T1/T2 N0 (LABC)
Radiation Therapy
Post-Mastectomy RT: T1/T2 N1 (LABC)
Radiation Therapy
Post-Mastectomy RT: T3 N0 (LABC)
Radiation Therapy
Post-Mastectomy RT: Advanced Stage
Radiation Therapy
Stage for Post-BCS Radiation (LABC)
Radiation Therapy
DCIS Post-BCS: Boost Indication Factors (LABC)
Radiation Therapy
DCIS Post-BCS: Sequential Boost Indicated
Radiation Therapy
DCIS Post-BCS: RT May Be Omitted (Select Cases)
Radiation Therapy
DCIS Post-BCS: Age ≤50 — Boost Indicated
Radiation Therapy
DCIS Post-BCS: Standard Whole Breast RT
Radiation Therapy
Post-BCS RT: T1/T2 N0 (LABC)
Radiation Therapy
APBI Eligibility for T1/T2 N0 Post-BCS (LABC)
Radiation Therapy
APBI: Accelerated Partial Breast Irradiation
Radiation Therapy
Post-BCS RT: T1/T2 N1 (LABC)
Radiation Therapy
Post-BCS RT: T3 N0 (LABC)
Radiation Therapy
Post-BCS RT: Advanced Stage
Radiation Therapy
DCIS Post-BCS: Boost Indication Factors
Radiation Therapy
APBI Eligibility for T1/T2 N0 Post-BCS
Radiation Therapy
Post-BCS RT: T1/T2 N0
Radiation Therapy
Post-BCS RT: T1/T2 N1
Radiation Therapy
Post-BCS RT: T3 N0
Radiation Therapy
Post-Mastectomy RT: DCIS
Radiation Therapy
Post-Mastectomy RT: T1/T2 N0
Radiation Therapy
Post-Mastectomy RT: T1/T2 N1
Radiation Therapy
Post-Mastectomy RT: T3 N0
RT — Oligo-metastatic BC
Oligo-metastatic BC: Eligibility Assessment
RT — Oligo-metastatic BC
Oligo-metastatic BC: Is Ablation of ALL Sites Feasible?
RT — Oligo-metastatic BC
Oligo-metastatic BC: SBRT Availability
RT — Oligo-metastatic BC
Oligo-metastatic BC: SBRT Regimens
RT — Oligo-metastatic BC
Oligo-metastatic BC: No SBRT — Conventional Ablative RT or Referral
Radiation Therapy — Technique
RT Planning: General CT-Based Planning Requirements
Radiation Therapy — Technique
RT Technique: Laterality of Breast Cancer
Radiation Therapy — Technique
Left-sided RT: Is Standard Technique Dosimetrically Acceptable?
Radiation Therapy — Technique
RT Special Techniques for Cardiac Sparing
Radiation Therapy — Technique
SRS/SBRT Indications
Follow-up
Post-Treatment Follow-up Schedule
Metastatic BC
MBC: Initial Staging Workup and Supportive Care
Metastatic BC
MBC: Receptor Status
Metastatic BC
HR+ MBC: Disease Burden
Metastatic BC
HR+ MBC Visceral Crisis: Chemotherapy
Metastatic BC
HR+ MBC: Treatment Line
Metastatic BC
HR+ MBC First-line: Patient Menopausal Status
Metastatic BC
HR+ MBC First-line: Premenopausal
Metastatic BC
HR+ MBC First-line: Postmenopausal
Metastatic BC
HR+/HER2− MBC: Second-line / Later Hormone Therapy
Metastatic BC
HER2+ MBC: Treatment Line
Metastatic BC
HER2+ MBC: First-line Therapy
Metastatic BC
HER2+ MBC: Second-line / Later Therapy
Metastatic BC
Metastatic TNBC: Treatment Line
Metastatic BC
Metastatic TNBC: First-line Chemotherapy
Metastatic BC
Metastatic TNBC: Second-line / Later Chemotherapy
Surgery in MBC
Surgery in Metastatic Breast Cancer
Palliative Radiotherapy
Palliative Radiotherapy: Metastatic Site
Palliative Radiotherapy — Bone
Bone Metastases: Does the Patient Merit Palliative RT?
Palliative Radiotherapy — Bone
Bone Metastases: Conservative Management
Palliative Radiotherapy — Bone
Bone Metastases: Extent and Skeletal-related Events
Palliative Radiotherapy — Bone
Focal Bone Metastases (No SRE): Palliative RT
Palliative Radiotherapy — Bone
Disseminated Bone Metastases (No SRE): Hemi-body Irradiation
Palliative Radiotherapy — Bone
Bone Metastases with SRE: Palliative RT
Palliative Radiotherapy — Brain
Brain Metastases: Fitness for Palliative RT
Palliative Radiotherapy — Brain
Brain Metastases: Best Supportive Care
Palliative Radiotherapy — Brain
Brain Metastases: Number of Lesions
Palliative Radiotherapy — Brain
Single Brain Metastasis: Favourable Criteria
Palliative Radiotherapy — Brain
Single Brain Metastasis (Favourable): Aggressive Local Treatment
Palliative Radiotherapy — Brain
Brain Metastases: Whole Brain Radiotherapy (WBRT)